Eigen Therapeutics Emerges From Stealth With $7M in Funding to Develop Therapies That Address Cancer Heterogeneity
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Eigen Therapeutics, the biotech startup on a mission to make cancer easier to find and eliminate, announced today their launch. They also announced a $7 million seed round led by Josh Kopelman at First Round Capital, with participation from Builders VC, Kevin Mahaffey, Hawktail, Matthew De Silva...
